Science Market Update

Jefferson U: Donations & NIH Funding Yields New Approaches to Treating Cancer

Posted by Rebecca Inch-Partridge on Tue, Nov 14, 2017

improve lab product sales at Jefferson university bioresearch product faire

Each year, The Sidney Kimmel Cancer Center (SKCC) at Jefferson University Hospital receives approximately $72 million in grants for cancer research from organizations such as Susan Komen for the Cure. This year the SKCC received a $3 million donation from Esperanza and David Neu in order to establish the Neu Center for Supportive Medicine and Cancer Survivorship. The purpose of the Neu Center is to serve as a comprehensive resource for psycho-social care and research.

Read More

Tags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, NIH funded Research Projects, Philadelphia, PA, NIH funding, Cancer Center, ThomJeff, cancer research funding, BioResearch Product Faire, NIH awards 2017, 2017 research funding

Harvard/Longwood Medical Area Institutes and Event

Posted by BCI Staff on Fri, Nov 10, 2017

Harvard Medical School, with facilities in the Longwood are aof Boston, is the third oldest medical school in the United States, founded in 1782, and is home to more than 700 students in the M.D. program, more than 140 in the D.M.D program, 556 in the Ph.D. program, and 155 in the M.D.‑Ph.D. program. Harvard Medical School is also affiliated with several teaching hospitals: the Beth Israel Deaconess Medical Center, the Brigham and Women’s Hospital and the Massachusetts General Hospital.

The Longwood Medical Area is known as one of the most prestigious educational, medical and research areas in the United States. Located along Longwood Avenue in Boston, Massachusetts, Longwood Medical Area (LMA) is made up of teaching hospitals, medical facilities, and non-medical facilities; as well as some top educational institutes, such as Harvard Medical School. 

Read More

Tags: 2014, Harvard University, 2013, Northeast, Longwood Medical Center, Boston, BioResearch Product Faire Event, Research, MA, Harvard, NIH funding

Stony Brook Awarded $6 M NIH Research Grant for New Anti-fungal Treatment

Posted by Rebecca Partridge on Fri, Jul 01, 2016

Bioresearch Grant for Potential New Anti-fungal Treatment

(Image courtesy of Wikimedia Commons)

Anti-fungal research at New York's Stony Brook University earned $6 million in grants from the National Institute of Health.  Dr. Maurizio del Poeta’s breakthrough in attacking deadly fungus came from a recent research project that yielded an unexpected result that might lead to a vaccine.  He and his team were searching for a gene that would metabolize a fungal sphingolipid.  Instead, the gene he mutated caused mice that were exposed to it to become resistant to fungal infections.  In an article on the Stony Brook University’s news site, Dr. Poeta said , “We think that this discovery will open the road to a new vaccination strategy against fungi.”

Read More

Tags: Northeast, New York, Stony Brook University, East Coast, NY, NIH grant, new research grant, SunySB, Fungal Infections, BioResearch Product Faire™, BioResearch Product Faire, NIH awards 2017, 2017 research funding

Columbia University Researchers Identify Neurodevelopmental Syndrome

Posted by Laura Braden on Tue, May 31, 2016

NeuroscienceNeuroscience and genetics are two important topics life scientists are consistently studying. Researchers from UC Davis found a promising treatment for Huntington's Disease, while UC San Francisco was awarded $185 million to build a new neuroscience research institute. Recently on the East Coast, a team of researchers from the Columbia University Medical Center discovered a new neurodevelopmental syndrome as well as the genetic makeup of the mutations that cause the syndrome. (Image courtesy of Allen Ajifo via Wikimedia Commons)

Read More

Tags: Northeast, Columbia University, Neuroscience, Columbia, Genetics, Neurology, NY, Columbia University Medical Center, 2016, BioResearch Product Faire, neurodevelopmental syndrome

Rutgers Scientists Find Link Between Antioxidant and Common Diseases

Posted by Laura Braden on Mon, Apr 25, 2016

Research at Rutgers University.

Liver disease and heart disease are two common ailments Americans suffer from. One in ten Americans suffers from liver disease, and heart disease is the leading cause of death in the country. The prominence of these diseases makes them common topics for life science research. Researchers from Rutgers, the State University of New Jersey recently found a connection between an antioxidant and liver and heart disease.  

Read More

Tags: Northeast, heart disease, NJ, New Jersey, Rutgers University, BioResearch Product Faire Event, Rutgers, 2016, Liver disease, TRIM21, Antioxidents

Harvard and Merck Partner for $20M Cancer Therapeutics Research

Posted by Laura Braden on Mon, Apr 18, 2016

AML in bone marrow, via Wikimedia Commons. Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.

Read More

Tags: Harvard University, Northeast, Leukemia, cancer research, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, longwood, 2016, cancer therapy, Merck

Thomas Jefferson Researchers Uncover Link Between Lung Cancer and Conserved Gene

Posted by Laura Braden on Wed, Mar 30, 2016

Life science research.

Lung cancer is one of the most common types of cancers and is responsible for the most cancer deaths each year. Due to its prevalence, lung cancer is a point of study for many researchers around the world. Just this year, researchers from the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have discovered that the gene Nitrilase 1 (Nit1) plays a large role in the proliferation of cancer cells. 

Read More

Tags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, Philadelphia, PA, ThomJeff, 2016, BioResearch Product Faire, Nitrilase 1, lung cancer, Nit1

Columbia University Increases Microbiome Research Potential

Posted by Laura Braden on Tue, Mar 29, 2016

Image of E. coli via NIAID on Wikimedia Commons.The human microbiome is a complex system of bacteria that live and interact in different tissues and organs throughout the body. This complex system is a growing area of focus for life science researchers looking to learn more about these interactions and functions. In order to help its researchers in this rapidly expanding field, Columbia University in New York has established both a working group and a new core facility to help increase research potential of the microbiome.

Read More

Tags: Northeast, microbiome, New York, Columbia University, Columbia, Research, NY, Columbia University Medical Center, 2016, BioResearch Product Faire, CUMC

Philadelphia Researchers Identify Why Type 2 Diabetics Resist Insulin

Posted by Laura Braden on Fri, Mar 18, 2016

Researching Type 2 Diabetes at UPenn. Type 2 Diabetes, the most common form of Diabetes, affects nearly twenty-nine million Americans. Sufferers' bodies resist any insulin being produced, causing blood glucose levels to rise above normal. This condition is associated not only with hyperglycemia, but also with excess fat in skeletal muscles, although the actual cause of insulin resistance has not previously been known.
Read More

Tags: Northeast, University of Pennsylvania, UPenn, Diabetes, insulin resistance, Philadelphia, PA, 2016, BioResearch Product Faire, Type 2 Diabetes

UPenn Opens Center for Advanced Cellular Therapeutics

Posted by Laura Braden on Tue, Mar 08, 2016

Perelman School of Medicine at the University of Pennsylvania.

The University of Pennsylvania in Philadelphia is one of the top research institutions in the world and is continuously expanding its research potential. Last year, the university opened a new Prematurity Research Center with the support of a $10 million donation from the March of Dimes Foundation of Philadelphia. Earlier this year, the university teamed up with the pharmaceutical company Novartis to open a new center on campus dedicated to cancer research, called the Novartis-Penn Center for Advanced Cellular Therapeutics (CACT)

The Center for Advanced Cellular Therapeutics, which is located on the University of Pennsylvania Medical Campus, is a $27 million project that will provide new laboratory and clinical space for physicians and scientists working to develop personalized cellular therapies for cancer treatments.

Read More

Tags: Northeast, University of Pennsylvania, UPenn, cancer research, Philadelphia, BioResearch Product Faire Event, PA, 2016, Novartis, Center for Advanced Cellular Therapeutics, Cell therapy

Subscribe to Company News